Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Non-cash Items: 2012-2025

Historic Non-cash Items for CorMedix (CRMD) over the last 8 years, with Sep 2025 value amounting to $3.3 million.

  • CorMedix's Non-cash Items fell 55.82% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 55.82%. This contributed to the annual value of $23.6 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, CorMedix's Non-cash Items stood at $3.3 million, which was up 38.25% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Non-cash Items ranged from a high of $23.6 million in Q4 2024 and a low of $337,075 during Q4 2021.
  • Its 3-year average for Non-cash Items is $7.7 million, with a median of $7.0 million in 2023.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 230.21% in 2022, then crashed by 94.20% in 2025.
  • Quarterly analysis of 5 years shows CorMedix's Non-cash Items stood at $337,075 in 2021, then soared by 230.21% to $1.1 million in 2022, then reached $6.5 million in 2023, then climbed by 14.92% to $23.6 million in 2024, then tumbled by 55.82% to $3.3 million in 2025.
  • Its last three reported values are $3.3 million in Q3 2025, $2.4 million for Q2 2025, and $530,000 during Q1 2025.